Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Marinus Pharmaceuticals Inc (MRNS)  
$8.79 0.14 (1.57%) as of 4:30 Tue 3/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 55,671,000
Market Cap: 489.35(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.86 - $11.21
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Marinus Pharmaceuticals is a pharmaceutical company focused on developing and commercializing products for patients suffering from rare genetic epilepsies and other seizure disorders. The U.S Food and Drug Administration approved the use of ZTALMY® (ganaxolone) oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder in patients two years of age and older. Ganaxolone is being developed in formulations for various routes of administration: intravenous and oral. Ganaxolone acts at both synaptic and extrasynaptic gamma-aminobutyric acid type A receptors, a target known for its anti-seizure, antidepressant and anxiolytic potential.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,803 21,803 38,528 41,369
Total Sell Value $215,409 $215,409 $374,962 $393,504
Total People Sold 5 5 5 8
Total Sell Transactions 5 5 15 18
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 128
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Shafer Christina CHIEF COMMERCIAL OFFICER   •       –      –    2024-02-20 4 AS $9.56 $20,583 D/D (2,153) 60,308 -8%     
   Manning Martha E SVP, GEN. COUNSEL & CORP. SEC.   •       –      –    2024-02-20 4 AS $9.57 $18,126 D/D (1,894) 52,966 -8%     
   Hulihan Joseph CHIEF MEDICAL OFFICER   •       –      –    2024-02-16 4 AS $9.98 $28,084 D/D (2,814) 66,635 -12%     
   Pfanstiel Steven CFO AND COO   •       –      –    2024-02-16 4 AS $9.97 $30,827 D/D (3,092) 71,697 -12%     
   Braunstein Scott CHAIRMAN AND CEO   •       •      –    2024-02-16 4 AS $9.94 $117,789 D/D (11,850) 223,512 -12%     
   Mayleben Timothy M   –       •      –    2024-01-18 4 A $0.00 $0 D/D 4,600 22,075     -
   Pfanstiel Steven CFO AND COO   •       –      –    2024-01-18 4 A $0.00 $0 D/D 25,465 74,789     -
   Ezickson Elan   –       •      –    2024-01-18 4 A $0.00 $0 D/D 4,600 10,200     -
   Noonberg Sarah B.   –       •      –    2024-01-18 4 A $0.00 $0 D/D 4,600 11,800     -
   Fischer Seth H.z.   –       •      –    2024-01-18 4 A $0.00 $0 D/D 4,600 10,626     -
   Silverstein Christine Berni   –       •      –    2024-01-18 4 A $0.00 $0 D/D 4,600 11,800     -
   Nochur Sara   –       •      –    2024-01-18 4 A $0.00 $0 D/D 4,600 10,950     -
   Manning Martha E SVP, GEN. COUNSEL & CORP. SEC.   •       –      –    2024-01-18 4 A $0.00 $0 D/D 21,835 54,860     -
   Johnson Marvin   –       •      –    2024-01-18 4 A $0.00 $0 D/D 4,600 11,800     -
   Braunstein Scott CHAIRMAN AND CEO   •       •      –    2024-01-18 4 A $0.00 $0 D/D 74,600 235,362     -
   Hulihan Joseph CHIEF MEDICAL OFFICER   •       –      –    2024-01-18 4 A $0.00 $0 D/D 21,835 69,449     -
   Shafer Christina CHIEF COMMERCIAL OFFICER   •       –      –    2024-01-18 4 A $0.00 $0 D/D 21,835 62,461     -
   Austin Charles   –       •      –    2024-01-18 4 A $0.00 $0 D/D 4,600 9,877     -
   Shafer Christina CHIEF COMMERCIAL OFFICER   •       –      –    2023-08-08 4 AS $8.93 $98 D/D (11) 40,626 -2%     
   Braunstein Scott CHAIRMAN AND CEO   •       •      –    2023-08-08 4 AS $8.94 $268 D/D (30) 160,762 -2%     
   Pfanstiel Steven CFO AND COO   •       –      –    2023-08-08 4 AS $8.93 $125 D/D (14) 49,324 -2%     
   Hulihan Joseph CHIEF MEDICAL OFFICER   •       –      –    2023-08-08 4 AS $8.93 $116 D/D (13) 47,614 -2%     
   Manning Martha E SVP, GEN. COUNSEL & CORP. SEC.   •       –      –    2023-08-08 4 AS $8.93 $98 D/D (11) 33,025 -2%     
   Shafer Christina CHIEF COMMERCIAL OFFICER   •       –      –    2023-08-07 4 AS $9.52 $22,705 D/D (2,385) 40,637 -4%     
   Braunstein Scott CHAIRMAN AND CEO   •       •      –    2023-08-07 4 AS $9.55 $61,244 D/D (6,413) 160,792 -4%     

  128 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed